Compare ICCC & FMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ICCC | FMY |
|---|---|---|
| Founded | 1982 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.5M | 51.7M |
| IPO Year | 1995 | N/A |
| Metric | ICCC | FMY |
|---|---|---|
| Price | $6.54 | $11.72 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 12.1K | 4.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.98% |
| EPS Growth | ★ 65.33 | N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $26,493,169.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $32.15 | ★ N/A |
| Revenue Growth | ★ 51.64 | N/A |
| 52 Week Low | $4.32 | $11.65 |
| 52 Week High | $7.60 | $12.39 |
| Indicator | ICCC | FMY |
|---|---|---|
| Relative Strength Index (RSI) | 53.29 | 33.05 |
| Support Level | $6.13 | N/A |
| Resistance Level | $6.87 | $12.34 |
| Average True Range (ATR) | 0.24 | 0.10 |
| MACD | -0.01 | -0.05 |
| Stochastic Oscillator | 68.57 | 4.62 |
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
First Trust Mortgage Income Fund is a United States-based diversified, closed-end management investment company. The fund's primary investment objective is to seek a high level of current income. Its secondary investment objective is to preserve capital. The fund pursues its objectives by investing predominantly in mortgage-backed securities representing part ownership in a pool of either residential or commercial mortgage loans that, in the opinion of the Fund's investment advisor, offer an attractive combination of credit quality, yield, and maturity.